Thermo Fisher Scientific has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for the Applied BioSystems™ TaqPath™ COVID-19 Diagnostic PCR Kit. The Thermo Scientific iCAP MSX ...

Thermo Fisher reported revenue for the quarter grew 5% to $11.40 billion in 2024 versus the same quarter of 2023. Organic ...

Strong demand, biotech funding optimism, and a bold 2025 outlook fuel investor confidence--here's what you need to know.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December ...

Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration With Thermo Fisher Scientific for Long-Acting ... The Thermo Scientific iCAP MSX ICP-MS ...